aspirin has been researched along with amphotericin b in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (27.78) | 29.6817 |
2010's | 10 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Baramee, A; Boonphong, S; Kittakoop, P; Mahidol, C; Puangsombat, P; Ruchirawat, S | 1 |
Aridoss, G; Jeong, YT; Kabilan, S; Parthiban, P; Prakash, M; Ramachandran, R | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Begent, RH; Lambert, HP; O'Grady, FW | 1 |
Mikhaĭlets, GA; Volynskaia, SL | 1 |
Madge, GE; Prout, GR; Randall, RE; Shadomy, HJ; Shadomy, S; Stacy, WK; Toone, EC; Utz, JP | 1 |
Alonzi, C; Buonomo, A; Corradini, C; Del Ninno, M; Nucera, E; Paludetti, G; Patriarca, G; Sabato, V; Schiavino, D | 1 |
Hu, X; Jia, J; Li, Y; Liu, Y; Song, Y; Wang, G; Yan, S; Zhang, N; Zheng, W; Zhou, Y | 1 |
Ogundeji, AO; Pohl, CH; Sebolai, OM | 1 |
Bartolomé, J; Candel, FJ; Lozano, MA; Lucena, R | 1 |
1 review(s) available for aspirin and amphotericin b
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for aspirin and amphotericin b
Article | Year |
---|---|
Amphotericin B and lysine acetylsalicylate in the combined treatment of nasal polyposis associated with mycotic infection.
Topics: Administration, Intranasal; Amphotericin B; Antifungal Agents; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fungi; Humans; Kaplan-Meier Estimate; Lysine; Mycoses; Nasal Polyps; Treatment Outcome | 2006 |
16 other study(ies) available for aspirin and amphotericin b
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Bioactive compounds from Bauhinia purpurea possessing antimalarial, antimycobacterial, antifungal, anti-inflammatory, and cytotoxic activities.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Antimalarials; Bauhinia; Benzoxepins; Bibenzyls; Flavanones; Microbial Sensitivity Tests; Molecular Structure; Plant Roots; Plants, Medicinal; Spiro Compounds; Thailand | 2007 |
Synthesis and spectral characterization of a new class of N-(N-methylpiperazinoacetyl)-2,6-diarylpiperidin-4-ones: antimicrobial, analgesic and antipyretic studies.
Topics: Analgesics; Analgesics, Non-Narcotic; Animals; Anti-Infective Agents; Bacteria; Drug Evaluation, Preclinical; Fungi; Mice; Microbial Sensitivity Tests; Molecular Structure; Pain; Piperidines; Spectrum Analysis; Structure-Activity Relationship | 2009 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Sensible prescribing. III. Acute otitis media and sore throat.
Topics: Amphotericin B; Ampicillin; Anti-Bacterial Agents; Aspirin; Cephalexin; Drug Prescriptions; Erythromycin; Haemophilus influenzae; Humans; Metronidazole; Nystatin; Otitis Media; Penicillins; Pharyngitis; Staphylococcus; Streptococcus pyogenes | 1975 |
[Effect of certain drug agents on the pyrogenic action of amphotericin B].
Topics: Administration, Oral; Aminopyrine; Amphotericin B; Analgesics; Animals; Anti-Inflammatory Agents; Aspirin; Body Temperature; Diphenhydramine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Hydrocortisone; Injections, Intravenous; Injections, Subcutaneous; Procaine; Pyrogens; Rabbits; Sodium Salicylate | 1973 |
Cryptococcal pyelonephritis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Amphotericin B; Arthritis, Rheumatoid; Aspirin; Cryptococcosis; Cryptococcus; Female; Hematuria; Humans; Kidney Papillary Necrosis; Male; Meningitis; Middle Aged; Proteinuria; Pyelonephritis; Pyuria; Urea; Urinary Tract Infections | 1968 |
In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis.
Topics: Amphotericin B; Antifungal Agents; Aspirin; Biofilms; Candida albicans; Microbial Sensitivity Tests | 2012 |
Repurposing of Aspirin and Ibuprofen as Candidate Anti-Cryptococcus Drugs.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspirin; Cell Death; Cell Line; Cryptococcosis; Cryptococcus; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Ibuprofen; Mice; RAW 264.7 Cells | 2016 |
[Peristomal cellulitis due to Magnusiomyces capitatus in a woman carrying percutaneous gastrostomy tube].
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspirin; Cellulitis; Dermatomycoses; Drug Combinations; Female; Flucytosine; Gastrostomy; Geotrichosis; Geotrichum; Humans; Magnesium Oxide; Microbial Sensitivity Tests; Surgical Wound Infection | 2017 |